New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 25, 2024 - Sun Pharma announced the FDA approval of Leqselvi (deuruxolitinib), for the treatment of adults with severe alopecia areata.
Download PDF
Return to publications
